Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...

A recent study from Bascom Palmer Eye Institute uncovered potential molecular evidence linking human papillomavirus (HPV) to ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic ...

The thyroid hormone thyroxine, or FT4, plays an indirect role in the development of MS that seems to be mediated by certain ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 11.67%, which has investors questioning if this is right time to sell.

Viking Therapeutics, Inc.’s VKTX share price has dipped by 5.22%, which has investors questioning if this is right time to buy.